LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jan 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-01-04

Reporting Person: GREENACRE MARTYN D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-04	Common Stock, $0.001 par value per share	A	120000	—	Acquired	120000	Direct

Footnotes

F1: On January 4, 2012 (the "Grant Date"), the Reporting Person was granted an award of 120,000 shares of common stock of NeoStem, Inc. (the "Company"), subject to all of the terms and conditions of the Company's 2009 Equity Compensation Plan and pursuant to the Company's Director Compensation Plan. The award was fully vested on the Grant Date.